UCSF Adult Inpatient Susceptibility Data (Gram-Positives)1
R-testing not applicable to organism and should be considered resistant, AMP-ampicillin, CLIN-clindamycin, CTRX-ceftriaxone, DAP-daptomycin, DOX-doxycycline, LZD-linezolid, NAF-nafcillin, PCN-penicillin G, T/S-trimethoprim/sulfamethoxazole, VANC-vancomycin
Total isolates include floor isolates and ICU isolates from Parnassus, MB Adult, and MZ
Reported as % susceptible, tested from all sites except as indicated
| Organism | Total Isolates | AMP/PCN2 | CLIN | CTRX | DAP | DOX | LZD | NAF | T/S | VANC |
|---|---|---|---|---|---|---|---|---|---|---|
| Staphylococcus aureus | 833 | N/A | 76 | N/A | 99 | 83 | 99 | 74 | 94 | 100 |
| MSSA | 591 | N/A | 80 | N/A | 99 | 92 | 99 | 99 | 96 | 100 |
| MRSA | 256 | N/A | 66 | N/A | 99 | 63 | 99 | N/A | 89 | 100 |
| Staphylococcus epidermidis | 227 | N/A | 62 | N/A | 100 | 74 | 99 | 29 | 55 | 100 |
| Staphylococcus lugdunesis | 40 | N/A | 92 | N/A | 100 | 92 | 100 | 93 | 100 | 100 |
| Viridans group streptococci3 | 120 | 75 | 81 | 96 |
| 71 |
|
|
| 100 |
| Streptococcus anginosus group | 61 | 100 | 81 | 100 |
| 62 |
|
|
| 100 |
| Streptococcus mitis | 53 | 60 | 82 | 96 |
| 83 |
|
|
| 100 |
| Enterococcus faecalis | 350 | 99 | N/A | N/A |
| 28 |
| N/A | N/A | 97 |
| Enterococcus faecium | 192 | 14 | N/A | N/A | 974 | 16 | 96 | N/A | N/A | 42 |
1Adult inpatient susceptibilities include data from 1/1/2025 - 12/31/2025; 2Reflects ampicillin for Enterococcus spp & penicillin G for Streptococcus spp; 3Viridans group streptococci include S. anginosus, S. constellatus, S. intermedius, S. milleri, S. mitis, S. mutans, S. oralis, S. parasanguinis, S. salivarius, & S. sobrinus; 4Represents susceptible dose-dependent isolates only